Analysis of 256 cases of basal cell carcinoma after either one-step or two-step surgery in a Japanese institution

Journal of Dermatology

Volumn 39, Issue 1, 2012, Pages 68-71

  Goto, Mizuki ^a   Kai, Yoshitaka ^a   Arakawa, Shoko ^a   Oishi, Masaki ^a   Ishikawa, Kazushi ^a   Anzai, Saburou ^a   Hatano, Yutaka ^a   Okamoto, Osamu ^a   Katagiri, Kazumoto ^a   Fujiwara, Sakuhei ^a   Shimizu, Fumiaki ^a   Kato, Aiko ^a   Shibuya, Hiromi ^a   Eshima, Nobuoki ^a   Terashi, Hiroto ^b  

^a OITA UNIVERSITY   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

basal cell carcinoma; excision; incomplete; local recurrence; metastasis; two step surgery

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BONE METASTASIS; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; EYELID; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JAPANESE; MAJOR CLINICAL STUDY; MALE; NOSE; PAROTID GLAND; PATIENT SAFETY; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE;

AGED; CARCINOMA, BASAL CELL; FEMALE; HUMANS; JAPAN; MALE; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SKIN; SKIN NEOPLASMS;

EID: 84855358986     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2011.01306.x     Document Type: Article

References (11)

1. Unlü RE, Altun S, Kerem M, Koç MN,. Is it really necessary to make wide excisions for basal cell carcinoma treatment? J Craniofac Surg 2009; 20 (6): 1989-1991.
2. Skelton LA,. The effective treatment of basal cell carcinoma. Br J Nurs 2009; 18 (6): 346, 348-350
3. Terashi H, Kurata S, Hashimoto H, et al. Adequate Depth of Excision for Basal Cell Carcinoma of the Nose. Ann Plast Surg 2002; 48 (2): 214-216. (Pubitemid 34127074)
4. Farhi D, Dupin N, Palangié A, Carlotti A, Avril MF,. Incomplete excision of basal cell carcinoma: rate and associated factors among 362 consecutive cases. Dermatol Surg 2007; 33 (10): 1207-1214. (Pubitemid 47508668)
5. Auw-Haedrich C, Frick S, Boehringer D, Mittelviefhaus H,. Histologic safety margin in basal cell carcinoma of the eyelid: correlation with recurrence rate. Ophthalmology 2009; 116 (4): 802-806.
6. Miller SJ, Alam M, Andersen J, et al. Basal cell and squamous cell skin cancers. J Natl Compr Canc Netw 2010; 8 (8): 836-864.
7. Cohen PR, Schulze KE, Nelson BR,. Basal cell carcinoma with mixed histology: a possible pathogenesis for recurrent skin cancer. Dermatol Surg 2006; 32 (4): 542-551.
8. Kaur P, Mulvaney M, Carlson JA,. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis. Am J Dermatopathol 2006; 28 (4): 293-307. (Pubitemid 44181566)
9. Kyrgidis A, Tzellos TG, Vahtsevanos K, Triaridis S,. New concepts for basal cell carcinoma. Demographic, clinical, histological risk factors, and biomarkers. A systematic review of evidence regarding risk for tumor development, susceptibility for second primary and recurrence. J Surg Res 2010; 159: 545-556.
10. Anthouli-Anagnostopoulou F, Hatziolou E,. Recurrent morphean basal cell carcinoma of the skin. A clinico-histopathological study of 97 cases. Adv Clin Path 2002; 6 (1): 17-24.
11. Lawrence CM, Haniffa M, Dahl MGC,. Formalin-fixed Mohs surgery (slow Mohs) for basal cell carcinoma: 5-year follow-up data. Br J Dermatol 2009; 160: 573-580.